617 related articles for article (PubMed ID: 26409344)
21. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
Thobois S; Guillouet S; Broussolle E
Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
[TBL] [Abstract][Full Text] [Related]
22. FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson's disease: A whole-brain multimodal imaging meta-analysis.
Albrecht F; Ballarini T; Neumann J; Schroeter ML
Neuroimage Clin; 2019; 21():101594. PubMed ID: 30514656
[TBL] [Abstract][Full Text] [Related]
23. Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
Gan C; Cao X; Sun H; Ye S; Shi J; Shan A; Gao M; Wan C; Zhang K; Yuan Y
Neurobiol Dis; 2024 Aug; 198():106560. PubMed ID: 38852751
[TBL] [Abstract][Full Text] [Related]
24. Neuroimaging in Glucocerebrosidase-Associated Parkinsonism: A Systematic Review.
Filippi M; Balestrino R; Basaia S; Agosta F
Mov Disord; 2022 Jul; 37(7):1375-1393. PubMed ID: 35521899
[TBL] [Abstract][Full Text] [Related]
25. Neuroimaging in Parkinson disease: from research setting to clinical practice.
Politis M
Nat Rev Neurol; 2014 Dec; 10(12):708-22. PubMed ID: 25385334
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
[TBL] [Abstract][Full Text] [Related]
27. Update on Molecular Imaging in Parkinson's Disease.
Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J
Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614
[TBL] [Abstract][Full Text] [Related]
28. Non-invasive imaging modalities to study neurodegenerative diseases of aging brain.
Annavarapu RN; Kathi S; Vadla VK
J Chem Neuroanat; 2019 Jan; 95():54-69. PubMed ID: 29474853
[TBL] [Abstract][Full Text] [Related]
29. Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease.
Christopher L; Strafella AP
J Neuropsychol; 2013 Sep; 7(2):225-40. PubMed ID: 23551844
[TBL] [Abstract][Full Text] [Related]
30. Transcranial sonography in relation to SPECT and MIBG.
Kajimoto Y; Miwa H; Kondo T
Int Rev Neurobiol; 2010; 90():48-62. PubMed ID: 20692493
[TBL] [Abstract][Full Text] [Related]
31. [Initial diagnosis of Parkinson's disease - neuroradiological diagnosis].
Orimo S
Rinsho Shinkeigaku; 2013; 53(11):977-80. PubMed ID: 24291851
[TBL] [Abstract][Full Text] [Related]
32. Connectivity Between Brain Networks Dynamically Reflects Cognitive Status of Parkinson's Disease: A Longitudinal Study.
Klobušiaková P; Mareček R; Fousek J; Výtvarová E; Rektorová I
J Alzheimers Dis; 2019; 67(3):971-984. PubMed ID: 30776007
[TBL] [Abstract][Full Text] [Related]
33. Analyzing the co-localization of substantia nigra hyper-echogenicities and iron accumulation in Parkinson's disease: A multi-modal atlas study with transcranial ultrasound and MRI.
Ahmadi SA; Bötzel K; Levin J; Maiostre J; Klein T; Wein W; Rozanski V; Dietrich O; Ertl-Wagner B; Navab N; Plate A
Neuroimage Clin; 2020; 26():102185. PubMed ID: 32050136
[TBL] [Abstract][Full Text] [Related]
34. The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging.
Ray NJ; Strafella AP
Mov Disord; 2012 Oct; 27(12):1484-92. PubMed ID: 23038645
[TBL] [Abstract][Full Text] [Related]
35. Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review.
Lenka A; Jhunjhunwala KR; Saini J; Pal PK
Parkinsonism Relat Disord; 2015 Jul; 21(7):683-91. PubMed ID: 25920541
[TBL] [Abstract][Full Text] [Related]
36. Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.
Lauretani F; Longobucco Y; Ravazzoni G; Gallini E; Salvi M; Maggio M
Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33670940
[TBL] [Abstract][Full Text] [Related]
37. The role of magnetic resonance imaging in the diagnosis of Parkinson's disease: a review.
Al-Radaideh AM; Rababah EM
Clin Imaging; 2016; 40(5):987-96. PubMed ID: 27288741
[TBL] [Abstract][Full Text] [Related]
38. Neuroimaging advances in Parkinson's disease.
Rispoli V; Schreglmann SR; Bhatia KP
Curr Opin Neurol; 2018 Aug; 31(4):415-424. PubMed ID: 29878908
[TBL] [Abstract][Full Text] [Related]
39. Neuroimaging in Parkinson's disease: a future perspective.
Brooks DJ
Neurodegener Dis Manag; 2015; 5(2):105-8. PubMed ID: 25894874
[No Abstract] [Full Text] [Related]
40. Drift in centrality of different brain regions in an anatomical neural network with Parkinson's disease: A view from complex network analysis.
Lei X; Huang B; Li H; Jiang H; Hu X; Zhang B
Neuroscience; 2015 Jul; 299():107-24. PubMed ID: 25937399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
